Status:
RECRUITING
Psoriatic Arthritis D2P Screening
Lead Sponsor:
Jessica Walsh
Conditions:
Psoriatic Arthritis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overarching goal of this study is to develop a direct-to-patient screening approach that will improve early Psoriatic Arthritis (PsA) detection in patients with psoriasis. Previously developed scr...
Detailed Description
Electronic medical record (EMR) systems will be used to identify psoriasis patients without a PsA diagnosis. Patients will be randomized to receive a PsA screening questionnaire (intervention group) o...
Eligibility Criteria
Inclusion
- Have an International Classification of Diseases (ICD) code diagnosis of psoriasis but without a confirmed diagnosis of Psoriatic Arthritis prior to study initiation
- Be age 18 or older
- Be geographically located within a reasonable proximity to the Rheumatology study site
Exclusion
- Have psoriasis and a confirmed diagnosis of psoriatic arthritis made or confirmed by a rheumatologist
Key Trial Info
Start Date :
July 22 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
18000 Patients enrolled
Trial Details
Trial ID
NCT04110522
Start Date
July 22 2019
End Date
December 31 2025
Last Update
March 17 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Pennsylvania
Philadelphia, Pennsylvania, United States, 19104
2
University of Utah
Salt Lake City, Utah, United States, 84112